Annual Working Capital
-$4.84 B
-$3.76 B-350.14%
31 December 2023
Summary:
AbbVie annual working capital is currently -$4.84 billion, with the most recent change of -$3.76 billion (-350.14%) on 31 December 2023. During the last 3 years, it has fallen by -$351.00 million (-7.82%). ABBV annual working capital is now -114.26% below its all-time high of $33.93 billion, reached on 31 December 2019.ABBV Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
-$15.28 B
-$7.18 B-88.63%
30 September 2024
Summary:
AbbVie quarterly working capital is currently -$15.28 billion, with the most recent change of -$7.18 billion (-88.63%) on 30 September 2024. Over the past year, it has dropped by -$13.73 billion (-886.25%). ABBV quarterly working capital is now -143.29% below its all-time high of $35.29 billion, reached on 31 March 2020.ABBV Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABBV Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -350.1% | -886.3% |
3 y3 years | -7.8% | -3703.1% |
5 y5 years | -1545.9% | -671.5% |
ABBV Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -350.1% | +33.4% | -3703.1% | at low |
5 y | 5 years | -114.3% | +33.4% | -143.3% | at low |
alltime | all time | -114.3% | +33.4% | -143.3% | at low |
AbbVie Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$15.28 B(+88.6%) |
June 2024 | - | -$8.10 B(+205.5%) |
Mar 2024 | - | -$2.65 B(-45.2%) |
Dec 2023 | -$4.84 B(+350.1%) | -$4.84 B(+212.4%) |
Sept 2023 | - | -$1.55 B(-54.3%) |
June 2023 | - | -$3.39 B(+207.4%) |
Mar 2023 | - | -$1.10 B(+2.5%) |
Dec 2022 | -$1.07 B(-85.2%) | -$1.07 B(-54.2%) |
Sept 2022 | - | -$2.35 B(-56.3%) |
June 2022 | - | -$5.37 B(-10.6%) |
Mar 2022 | - | -$6.01 B(-17.3%) |
Dec 2021 | -$7.27 B(+61.9%) | -$7.27 B(-1813.7%) |
Sept 2021 | - | $424.00 M(-115.8%) |
June 2021 | - | -$2.69 B(-50.1%) |
Mar 2021 | - | -$5.38 B(+19.9%) |
Dec 2020 | -$4.49 B(-113.2%) | -$4.49 B(+282.9%) |
Sept 2020 | - | -$1.17 B(-65.4%) |
June 2020 | - | -$3.39 B(-109.6%) |
Mar 2020 | - | $35.29 B(+4.0%) |
Dec 2019 | $33.93 B(<-9900.0%) | $33.93 B(+1169.5%) |
Sept 2019 | - | $2.67 B(-245.2%) |
June 2019 | - | -$1.84 B(-461.7%) |
Mar 2019 | - | $509.00 M(-273.1%) |
Dec 2018 | -$294.00 M | -$294.00 M(-109.6%) |
Sept 2018 | - | $3.08 B(-191.1%) |
June 2018 | - | -$3.38 B(-199.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | $3.39 B(-26.1%) |
Dec 2017 | $4.58 B(-28.5%) | $4.58 B(-22.3%) |
Sept 2017 | - | $5.90 B(+25.4%) |
June 2017 | - | $4.70 B(-29.8%) |
Mar 2017 | - | $6.70 B(+4.6%) |
Dec 2016 | $6.41 B(+18.2%) | $6.41 B(-10.9%) |
Sept 2016 | - | $7.19 B(-4.4%) |
June 2016 | - | $7.52 B(+26.2%) |
Mar 2016 | - | $5.96 B(+10.0%) |
Dec 2015 | $5.42 B(+15.6%) | $5.42 B(-40.4%) |
Sept 2015 | - | $9.10 B(+61.9%) |
June 2015 | - | $5.62 B(+28.9%) |
Mar 2015 | - | $4.36 B(-7.0%) |
Dec 2014 | $4.69 B(-57.3%) | $4.69 B(-57.1%) |
Sept 2014 | - | $10.92 B(-4.9%) |
June 2014 | - | $11.48 B(+3.3%) |
Mar 2014 | - | $11.11 B(+1.3%) |
Dec 2013 | $10.97 B(+27.9%) | $10.97 B(+13.5%) |
Sept 2013 | - | $9.67 B(+9.2%) |
June 2013 | - | $8.86 B(+8.6%) |
Mar 2013 | - | $8.16 B(-4.9%) |
Dec 2012 | $8.58 B(+488.7%) | $8.58 B(+54.2%) |
Sept 2012 | - | $5.56 B(+382.4%) |
June 2012 | - | $1.15 B(-6.7%) |
Mar 2012 | - | $1.24 B(-15.2%) |
Dec 2011 | $1.46 B(-67.3%) | $1.46 B |
Dec 2010 | $4.46 B | - |
FAQ
- What is AbbVie annual working capital?
- What is the all time high annual working capital for AbbVie?
- What is AbbVie annual working capital year-on-year change?
- What is AbbVie quarterly working capital?
- What is the all time high quarterly working capital for AbbVie?
- What is AbbVie quarterly working capital year-on-year change?
What is AbbVie annual working capital?
The current annual working capital of ABBV is -$4.84 B
What is the all time high annual working capital for AbbVie?
AbbVie all-time high annual working capital is $33.93 B
What is AbbVie annual working capital year-on-year change?
Over the past year, ABBV annual working capital has changed by -$3.76 B (-350.14%)
What is AbbVie quarterly working capital?
The current quarterly working capital of ABBV is -$15.28 B
What is the all time high quarterly working capital for AbbVie?
AbbVie all-time high quarterly working capital is $35.29 B
What is AbbVie quarterly working capital year-on-year change?
Over the past year, ABBV quarterly working capital has changed by -$13.73 B (-886.25%)